• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of vasopressin on pulmonary and systemic vascular mechanics.

作者信息

Wallace A W, Tunin C M, Shoukas A A

机构信息

Department of Biomedical Engineering, Johns Hopkins Medical School, Baltimore, Maryland 21205.

出版信息

Am J Physiol. 1989 Oct;257(4 Pt 2):H1228-34. doi: 10.1152/ajpheart.1989.257.4.H1228.

DOI:10.1152/ajpheart.1989.257.4.H1228
PMID:2801982
Abstract

The direct effects of vasopressin on the resistance and capacitance properties of the pulmonary and systemic vasculature were studied in nine aneural dogs on systemic and pulmonary bypass. The systemic and pulmonary pressure-flow, the systemic and pulmonary arterial pressure-volume, and the systemic and pulmonary venous pressure-volume relationships were determined for five levels of infused vasopressin. Vasopressin levels of approximately 10, 30, 150, 300, and 500 pg/ml were achieved by intravenous infusions. Samples of venous blood were drawn before and after each set of pressure-flow and pressure-volume relationships for the determination of vasopressin level by radioimmunoassay. A linear relationship was found between vasopressin level and systemic vascular resistance. Systemic vascular resistance increased 0.072 +/- 0.011 mmHg.kg.min.ml-1 for a change in vasopressin level of 100 pg/ml. Vasopressin did not affect pulmonary vascular resistance or any vascular compliance. High doses of infused arginine vasopressin were necessary to elicit substantial vasoconstriction.

摘要

相似文献

1
Effects of vasopressin on pulmonary and systemic vascular mechanics.
Am J Physiol. 1989 Oct;257(4 Pt 2):H1228-34. doi: 10.1152/ajpheart.1989.257.4.H1228.
2
Vasopressin-induced pulmonary vasodilation in rats.血管加压素诱导的大鼠肺血管舒张
Am J Physiol. 1989 Aug;257(2 Pt 2):H415-22. doi: 10.1152/ajpheart.1989.257.2.H415.
3
The pulmonary and systemic circulatory response to dopamine infusion.多巴胺输注时的肺循环和体循环反应。
Br J Pharmacol. 1969 Nov;37(3):618-26. doi: 10.1111/j.1476-5381.1969.tb08500.x.
4
Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.全身血管收缩调节麻醉大鼠肺血管和气道对血管收缩剂的反应。
Exp Lung Res. 2015;41(6):324-34. doi: 10.3109/01902148.2015.1032448. Epub 2015 Jul 7.
5
Effects of low-volume hemoglobin glutamer-200 versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model.低容量血红蛋白谷氨酰胺-200与生理盐水及精氨酸加压素复苏对犬失血性休克模型全身和骨骼肌血流及氧合的影响
Crit Care Med. 2007 Sep;35(9):2101-9. doi: 10.1097/01.CCM.0000277040.31978.3D.
6
The effects of oxytocin on the pulmonary and systemic circulation in pregnant ewes.
Anaesth Intensive Care. 1992 May;20(2):199-202. doi: 10.1177/0310057X9202000215.
7
[Effect of Aminorex (Manocil) on hemodynamics of the pulmonary and systemic circulation during intravenous administration in dogs].[氨苯唑啉(马诺西尔)静脉注射对犬肺循环和体循环血流动力学的影响]
Naunyn Schmiedebergs Arch Pharmakol. 1969;264(4):389-405.
8
5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog.5,6-环氧二十碳三烯酸可降低犬肺血管阻力的增加。
Am J Physiol. 1998 Jul;275(1):H100-9. doi: 10.1152/ajpheart.1998.275.1.H100.
9
The influence of propranolol pretreatment on acute tolerance to norepinephrine effects on the systemic and pulmonary circulations in dogs.普萘洛尔预处理对犬去甲肾上腺素对体循环和肺循环作用的急性耐受性的影响。
Pharmacology. 1970;4(4):209-28. doi: 10.1159/000136140.
10
Effects of arginine vasopressin on capillary filtration in the cat ileum.精氨酸加压素对猫回肠毛细血管滤过的影响。
Gastroenterology. 1977 Dec;73(6):1290-5.

引用本文的文献

1
Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?血管加压素及其类似物在感染性休克患者中的应用:圣杯还是未兑现的承诺?
Crit Care. 2025 Jul 29;29(1):333. doi: 10.1186/s13054-025-05540-2.
2
Obstructive Shock, from Diagnosis to Treatment.阻塞性休克:从诊断到治疗
Rev Cardiovasc Med. 2022 Jun 29;23(7):248. doi: 10.31083/j.rcm2307248. eCollection 2022 Jul.
3
Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.血管加压素在足月新生儿伴难治性系统性低血压的肺动脉高压中的辅助治疗作用。
J Perinatol. 2024 Oct;44(10):1448-1453. doi: 10.1038/s41372-024-02015-0. Epub 2024 Jul 4.
4
Sepsis-Induced myocardial dysfunction: heterogeneity of functional effects and clinical significance.脓毒症诱导的心肌功能障碍:功能效应的异质性及临床意义
Front Cardiovasc Med. 2023 Jul 14;10:1200441. doi: 10.3389/fcvm.2023.1200441. eCollection 2023.
5
Early Recognition and Risk Stratification in Cardiogenic Shock: Well Begun Is Half Done.心源性休克的早期识别与风险分层:良好的开端是成功的一半。
J Clin Med. 2023 Apr 1;12(7):2643. doi: 10.3390/jcm12072643.
6
Alternatives to norepinephrine in septic shock: Which agents and when?感染性休克中去甲肾上腺素的替代药物:哪些药物以及何时使用?
J Intensive Med. 2022 Jun 12;2(4):223-232. doi: 10.1016/j.jointm.2022.05.001. eCollection 2022 Oct.
7
Vasopressin and Breathing: Review of Evidence for Respiratory Effects of the Antidiuretic Hormone.血管加压素与呼吸:抗利尿激素呼吸效应的证据综述
Front Physiol. 2021 Oct 26;12:744177. doi: 10.3389/fphys.2021.744177. eCollection 2021.
8
Vasopressors for the Treatment and Prophylaxis of Spinal Induced Hypotension during Caesarean Section.用于剖宫产术中治疗和预防脊髓诱导性低血压的血管升压药。
Turk J Anaesthesiol Reanim. 2021 Feb;49(1):3-10. doi: 10.5152/TJAR.2020.70. Epub 2020 May 5.
9
Terlipressin versus norepinephrine to prevent milrinone-induced systemic vascular hypotension in cardiac surgery patient with pulmonary hypertension.特利加压素与去甲肾上腺素预防肺动脉高压心脏手术患者米力农诱导的系统性血管性低血压的比较
Ann Card Anaesth. 2019 Apr-Jun;22(2):136-142. doi: 10.4103/aca.ACA_83_18.
10
Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans.托伐普坦治疗高容量性低钠血症的不可预测性:血管加压素受体拮抗剂作用的病例回顾
Case Rep Endocrinol. 2014;2014:807054. doi: 10.1155/2014/807054. Epub 2014 Jan 8.